Vijay Kumar Prajapati

Author

Also Known As

Atul Kumar, Dr. Vijay Kumar Prajapati, Dr. Vijay Kumar Prajapati, Prajapati, Vijay Kumar, V Prajapati, V. K. PRAJAPATI, V. K. Prajapati, V. Prajapati, V.K. Prajapati, VIJAY PRAJAPATI

201

Publications

6.6K

Citations

H-Index

143

Concepts

All Affiliations

Central University of Rajasthan Banaras Hindu University Institute of Medical Sciences Indian Institute of Technology Jodhpur Instituut voor Tropische Geneeskunde

About

Vijay Kumar Prajapati is an author at Central University of Rajasthan specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	44	2.9K
2	Natural Sciences	9	9	561
3	Engineering	8	8	301
4	Public Health	3	3	879
5	Education	1	1	30

Vijay Kumar Prajapati

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Austin E Schumacher, Hmwe Hmwe Kyu, Amirali Aali, The Lancet Mortality RatesCovid-19 EpidemiologyEpidemiology Of AgingCovid-19Pandemic Management	2024	839
Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection Mudassar Ali, Rajan Kumar Pandey, Nazia Khatoon, Scientific Reports	2017	385
Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach Nazia Khatoon, Rajan Kumar Pandey, Vijay Kumar Prajapati Scientific Reports	2017	359
Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use Shyam Sundar, Avinash Singh, Madhukar Rai, Clinical Infectious Diseases	2012	295
Novel Immunoinformatics Approaches to Design Multi-epitope Subunit Vaccine for Malaria by Investigating Anopheles Salivary Protein Rajan Kumar Pandey, Tarun Kumar Bhatt, Vijay Kumar Prajapati Scientific Reports	2018	248
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent Hideo Imamura, Tim Downing, Frederik Van den Broeck, eLife GeneticsGenomicsVisceral LeishmaniasisParasite GenomicsDrug Resistance	2016	187
Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes Vijay Kumar Prajapati, Kalpana Awasthi, Sakshi Gautam, Journal of Antimicrobial Chemotherapy	2011	150
Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection Rajan Kumar Pandey, Rupal Ojha, Veeranarayanan Surya Aathmanathan, Vaccine VaccinationReverse VaccinologyMedicineImmunoinformatics ApproachesVaccine Target	2018	149
Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases Banoth Karan Kumar, Faheem Faheem, Kondapalli Venkata Gowri Chandra Sekhar, Journal of Biomolecular Structure and Dynamics	2020	114
Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis Vasundhra Bhandari, Arpita Kulshrestha, Deepak Kumar Deep, PLoS neglected tropical diseases	2012	112

Page 1